<DOC>
	<DOCNO>NCT02265419</DOCNO>
	<brief_summary>Heart-surgery use heart-lung-machine trigger development full-blown SIRS ( Systemic Inflammatory Response Syndrom ) multi organ failure severe sepsis course disease . For treatment full-blown SIRS extracorporeal treatment like Cytosorb-Adsorber clinical testing . The Cytosorb-Adsorber CE-signed medical device approval treatment severe sepsis hyperinflammation . The adsorber remove not-specific cytokine inflammation mediator patient blood . In study ( case-observation compassionate use ) effect extracorporeal treatment Cytosorb-Adsorber reduction postoperative hyperinflammation SIRS heart-surgery use heart-lung-machine observed . The aim study record influence treatment Cytosorb-Adsorber course hyperinflammation multi organ failure comparison historic control group .</brief_summary>
	<brief_title>Use Extracorporeal Treatment With Cytosorb-Adsorber Reduction SIRS Heart Surgery Patients</brief_title>
	<detailed_description>All patient underlie heart surgery use heart-lung-machine fullfilling inclusion-criteria sreened study . The study take place two surgical intensive care unit ( PIT I PIT II ) university hospital Rostock , Germany . The extracorporeal treatment Cytosorb-Adsorber start 6 hour end operation write informed consent obtain participant patient ` representative direct consent could receive . The extracorporeal treatment duration 24 hour observation time 90 day . The aim study record influence treatment Cytosorb-Adsorber course hyperinflammation multi organ failure comparison historic control group . The main-criterion significant difference mean-SOFA ( Sequential Organ Failure Assessment ) -score Cytosorb-group historic control group 7 day . Beside criterion 30- 90-day survival , time respirator-therapy , length ICU stay , severity Critical Illness Polyneuropathy dosage vasopressor day 1 , 2 3 . From patient basic demographic information , illness severity ( APACHE II , SOFA score ) , microbiological result , pre-morbidity , clinical outcome study cohort record . At day 1-4 , 7 , 14 , 30 before/after extracorporeal treatment patient screen clinical immunological data : hemodynamic , inflammation , coagulation , hemolysis , temperature , organ function blood parameter cytokine . `` Day 1 '' define day begin extracorporeal treatment . At day 1 , 2 7 hemodynamic monitoring do PiCCO-System ( PULSION Medical Systems , Feldkirchen , Germany ) . For dynamic measurement liver function use LiMON-System ( base indocyanin green plasma disappearance rate , PULSION ) day 1 , 2 7 .</detailed_description>
	<mesh_term>Multiple Organ Failure</mesh_term>
	<criteria>After heart surgery heartlungmachine 2 positive SIRS criterion within 6 hour postoperative need &gt; 1,9 liter kristalloids within 6 hour postoperative centralvenous oxygen saturation &gt; 75 % within 6 hour postoperative need vasopressor ( ≥0,06 µg/Kg/Min ) within 6 hour postoperative Bleeding Thrombocyten &lt; 20.000 /µl , INR &gt; 3,0 HIVTest positive Hepatitis C positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>hyperinflammation , Cytosorb</keyword>
</DOC>